Reaktionsgleichung
[N:1]1([CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][N:13]2[C:18](=[O:19])[CH2:17][O:16][CH2:15][C:14]2=[O:20])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[CH3:21][C:22]1[CH:23]=[CH:24][C:25]([S:28]([OH:31])(=[O:30])=[O:29])=[CH:26][CH:27]=1.[OH-].[Na+:33]>>[N:1]1([CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][NH:13][C:14](=[O:20])[CH2:15][O:16][CH2:17][C:18]([O-:29])=[O:19])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1.[Na+:33].[S:28]([C:25]1[CH:26]=[CH:27][C:22]([CH3:21])=[CH:23][CH:24]=1)([O-:31])(=[O:30])=[O:29].[Na+:33]Komponenten
5
Versuchsvorschrift
Preparation in situ from 4-(6-piperidinohexyl)-3,5-dioxomorpholine.p-toluenesulfonate. 43 milligrams (0.095 millimole) of 4-(6-piperidinohexyl)-3,5-dioxomorpholine.p-toluenesulfonate (prepared as described in Example IX) was dissolved in 2 milliliters of 0.1N sodium hydroxide (0.2 millimole) to obtain an aqueous solution of sodium [2-(6-piperidinohexyl)amino-2-oxoethoxy]acetate and sodium tosylate. The solution had the following spectral characteristics:
Quellen und Nachweise
- ORD-Eintrag
- ord-ac36745856d74bcdac67681dac197dd1
- Quelldatensatz
- uspto-grants-1978_10
- Patentnummer
- US04123538
Verknüpfte Notizen
Wird geladen…